These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 32589135

  • 1. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies
.
    Hansrivijit P, Puthenpura MM, Ghahramani N.
    Clin Nephrol; 2020 Sep; 94(3):117-126. PubMed ID: 32589135
    [Abstract] [Full Text] [Related]

  • 2. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH, Reiser J, Cara-Fuentes G, Wei C, Matar D, Wang H, Alachkar N, Johnson RJ.
    Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
    [Abstract] [Full Text] [Related]

  • 3. Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.
    Hansrivijit P, Cheungpasitporn W, Thongprayoon C, Ghahramani N.
    BMC Nephrol; 2020 Apr 15; 21(1):134. PubMed ID: 32293308
    [Abstract] [Full Text] [Related]

  • 4. Abatacept efficacy in steroid-resistant minimal-change disease revealed by the speed of proteinuria reduction after the start of abatacept
.
    Dado D, Parikh S, Ayoub I, Rovin B, Nadasdy T, Hebert L.
    Clin Nephrol; 2018 May 15; 89(5):376-380. PubMed ID: 29249233
    [Abstract] [Full Text] [Related]

  • 5. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
    Burke GW, Chandar J, Sageshima J, Ortigosa-Goggins M, Amarapurkar P, Mitrofanova A, Defreitas MJ, Katsoufis CP, Seeherunvong W, Centeno A, Pagan J, Mendez-Castaner LA, Mattiazzi AD, Kupin WL, Guerra G, Chen LJ, Morsi M, Figueiro JMG, Vianna R, Abitbol CL, Roth D, Fornoni A, Ruiz P, Ciancio G, Garin EH.
    Pediatr Nephrol; 2023 Jan 15; 38(1):145-159. PubMed ID: 35507150
    [Abstract] [Full Text] [Related]

  • 6. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R, Gagliardini E, Ruggiero B, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2016 Mar 01; 310(5):F335-41. PubMed ID: 26697986
    [Abstract] [Full Text] [Related]

  • 7. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM, Ezzat DA, Doudar NA, Adel M.
    Iran J Kidney Dis; 2018 Mar 01; 12(2):107-111. PubMed ID: 29507273
    [Abstract] [Full Text] [Related]

  • 8. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
    Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R.
    Pediatr Int; 2019 Dec 01; 61(12):1250-1256. PubMed ID: 31513327
    [Abstract] [Full Text] [Related]

  • 9. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.
    Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, Johnson RJ.
    Kidney Int; 2010 Aug 01; 78(3):296-302. PubMed ID: 20485332
    [Abstract] [Full Text] [Related]

  • 10. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
    Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
    Kidney Int; 2004 May 01; 65(5):1690-702. PubMed ID: 15086908
    [Abstract] [Full Text] [Related]

  • 11. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
    Pediatr Nephrol; 2014 Aug 01; 29(8):1363-71. PubMed ID: 24263531
    [Abstract] [Full Text] [Related]

  • 12. Abatacept in B7-1-positive proteinuric kidney disease.
    Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, Chen L, Ciancio G, Faridi MH, Behr D, Campbell KN, Chang JM, Chen HC, Oh J, Faul C, Arnaout MA, Fiorina P, Gupta V, Greka A, Burke GW, Mundel P.
    N Engl J Med; 2013 Dec 19; 369(25):2416-23. PubMed ID: 24206430
    [Abstract] [Full Text] [Related]

  • 13. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
    Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
    Kidney Int; 2003 Oct 19; 64(4):1232-40. PubMed ID: 12969141
    [Abstract] [Full Text] [Related]

  • 14. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
    Alshami A, Roshan A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Sibley M, Mammen C, Matsell DG, Pediatric Nephrology Clinical Pathway Development Team.
    Pediatr Nephrol; 2017 Oct 19; 32(10):1897-1905. PubMed ID: 28540445
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor 3 (TLR-3), TLR-4 and CD80 expression in peripheral blood mononuclear cells and urinary CD80 levels in children with idiopathic nephrotic syndrome.
    Mishra OP, Kumar R, Narayan G, Srivastava P, Abhinay A, Prasad R, Singh A, Batra VV.
    Pediatr Nephrol; 2017 Aug 19; 32(8):1355-1361. PubMed ID: 28210837
    [Abstract] [Full Text] [Related]

  • 16. Recurrence of nephrotic syndrome following kidney transplantation is associated with initial native kidney biopsy findings.
    Pelletier JH, Kumar KR, Engen R, Bensimhon A, Varner JD, Rheault MN, Srivastava T, Straatmann C, Silva C, Davis TK, Wenderfer SE, Gibson K, Selewski D, Barcia J, Weng P, Licht C, Jawa N, Kallash M, Foreman JW, Wigfall DR, Chua AN, Chambers E, Hornik CP, Brewer ED, Nagaraj SK, Greenbaum LA, Gbadegesin RA.
    Pediatr Nephrol; 2018 Oct 19; 33(10):1773-1780. PubMed ID: 29982878
    [Abstract] [Full Text] [Related]

  • 17. Patients with primary focal segmental glomerulosclerosis with detectable urinary CD80 are more similar to patients with minimal change disease in clinicopathological features.
    Gong X, Huang J, Zhang Y, Wang F, Wang X, Meng L, Cheng X, Liu G, Cui Z, Zhao M.
    Ren Fail; 2023 Oct 19; 45(2):2279642. PubMed ID: 37942512
    [Abstract] [Full Text] [Related]

  • 18. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Société de Néphrologie.
    Meyrier A, Noël LH, Auriche P, Callard P.
    Kidney Int; 1994 May 19; 45(5):1446-56. PubMed ID: 8072258
    [Abstract] [Full Text] [Related]

  • 19. B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.
    Delville M, Baye E, Durrbach A, Audard V, Kofman T, Braun L, Olagne J, Nguyen C, Deschênes G, Moulin B, Delahousse M, Kesler-Roussey G, Beaudreuil S, Martinez F, Rabant M, Grimbert P, Gallazzini M, Terzi F, Legendre C, Canaud G.
    J Am Soc Nephrol; 2016 Aug 19; 27(8):2520-7. PubMed ID: 26701979
    [Abstract] [Full Text] [Related]

  • 20. Urinary CD80 excretion is a predictor of good outcome in children with primary nephrotic syndrome.
    Ling C, Liu X, Shen Y, Chen Z, Fan J, Jiang Y, Meng Q.
    Pediatr Nephrol; 2018 Jul 19; 33(7):1183-1187. PubMed ID: 29569191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.